Sr. Director, Global Market Access and Pricing Lead - Oncology

Job Title: Sr. Director, Global Market Access and Pricing Lead - Oncology

Location: Cambridge, MA

About the Job

Sanofi Genzyme’s Oncology franchise has a diverse and fast-growing portfolio. This includes the late-stage launching assets (Sarclisa® / isatuximab / anti-CD38) in multiple myeloma, as well as earlier compounds in oncology. We are rapidly advancing a robust and reinvigorated oncology pipeline in different malignancies including colorectal and other GI cancers, lung cancers, and hematology.

Oncology is at the forefront of the key issues hence leadership in access policy is critical for Sanofi success and support timely access. We are navigating in an uncertain and evolving environment, where different structural access hurdles have been identified/prioritized. Market Access is central to guiding cross-functional efforts to mitigate access-related risks, and prepare for pipeline future launches​.

The primary purpose of the role is to lead development, update and execution of the Global Market Access and Pricing strategy, plans and tactics for the hematology and solid tumor pipeline through best-in-class methodologies. Main areas of focus will be as follows:

• Lead all relevant strategic and tactical activities to support the Market Access inputs to the pipeline assets strategy (landscaping, payer requirements, value positioning, pricing/access assumptions…)

• Lead cross-brand projects as part of the Access policy workforce, in collaboration with other functions (e.g., combinations challenges, alternative endpoints, etc.)

This is a highly collaborative role which will coordinate the relevant cross-functional projects and that must work cohesively with all relevant stakeholders within Market Access (HEVA, GMAX CoE, Affiliates…) and beyond (Commercial, Clinical, Medical, Biostats etc…) to build successful access and pricing strategies, plan and tools in order to realize the full pricing and access potential of Sanofi solutions.

The role will report to the Global Head of Market Access & Pricing - Oncology.

The position will provide exposure to pre-POC, post-PoC and pre-launch activities.

We are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases and blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.

Main Responsibilities:

• As per task / indication / asset, the incumbent will lead the efforts according to needs, priorities and ramp-up. Increasing autonomy expected to grow over time.

• Collaborates to the development and supports execution of the access and pricing strategy in partnership with the therapeutic global cross-functional colleagues (e.g. Commercial, Clinical, medical, regulatory etc.)

• Partner effectively with relevant departments (e.g. Commercial, Clinical Development, Regulatory Affairs, Medical Affairs, HEOR…) to influence the market assessment, product positioning, and TPP by providing strategic input regarding market access, reimbursement and pricing information throughout the product life cycle.

• For each indications / asset under scope, responsible for the timely execution of assigned activities pertaining to the following areas (lead or support as per cases), such as:

• Foundational knowledge of disease and payer unmet need

• Competitive assessment

• Early market access success factors / risks identification

• Fact based early potential assessments (price/access assumptions for forecasting) and scenario development

• Informed market access input to development plan & pivotal trial design

• Coordinates the relevant Market Access cross-functional working groups / sub-team / projects ensuring relevant input / engagement from key markets

• Develops and maintains a high level of knowledge with regards to the scientific, clinical, strategic pricing and commercial developments relevant to the assets/indications under scope

• Develops and maintains a robust und